```html

Yellowing of the Eyes (Icterus)

What is Yellowing of the eyes (icterus)?

Yellowing of the eyes, medically known as icterus or jaundice of the sclera, is a visual sign that the whites of the eyes (the sclera) have taken on a yellow hue. The discoloration occurs when excess bilirubin—a yellow‑orange pigment produced during the normal breakdown of red blood cells—accumulates in the bloodstream and deposits in tissues, including the eye. While mild scleral icterus may be harmless, it often signals an underlying problem with the liver, gallbladder, pancreas, or red blood cells.

Because the sclera is relatively thin and contains few blood vessels, it becomes visibly yellow before the skin does, making it a useful early indicator for clinicians.

Common Causes

There are many conditions that can raise bilirubin levels enough to cause scleral icterus. The most frequent causes fall into three broad categories: liver disease, biliary obstruction, and hemolysis. Below are 10 common culprits:

• Acute viral hepatitis (A, B, C) – Inflammation impairs bilirubin processing.
• Alcoholic or non‑alcoholic fatty liver disease (NAFLD) – Fat accumulation damages hepatocytes.
• Cirrhosis – Scarring reduces the liver’s ability to conjugate bilirubin.
• Gallstones (cholelithiasis) causing biliary obstruction – Blocked bile flow backs up bilirubin.
• Pancreatic head cancer – Can compress the common bile duct.
• Primary sclerosing cholangitis (PSC) or primary biliary cholangitis (PBC) – Chronic bile‑duct inflammation.
• Hemolytic anemia (e.g., sickle cell disease, autoimmune hemolysis) – Accelerated red‑cell breakdown releases more bilirubin.
• Gilbert’s syndrome – A benign genetic reduction in bilirubin‑conjugating enzymes.
• Drug‑induced liver injury – Acetaminophen overdose, certain antibiotics, or herbal supplements.
• Newborn physiologic jaundice – Immature liver enzymes in infants (usually resolves within 2 weeks).

Less common but important causes include: cholestasis of pregnancy, sepsis, thyroid storm, and infiltrative diseases such as amyloidosis or sarcoidosis.

Associated Symptoms

Other signs often accompany scleral icterus, helping to narrow the likely cause:

• Dark urine (bilirubin excreted in urine)
• Pale, clay‑colored stools (absence of bile pigment)
• Abdominal pain, especially in the right upper quadrant
• Pruritus (itching) – common in cholestatic disorders
• Fatigue, weakness, or loss of appetite
• Fever or chills (suggesting infection)
• Weight loss
• Swelling of the abdomen (ascites) or legs (edema)
• Confusion or “hepatic encephalopathy” in advanced liver disease

When jaundice is due to hemolysis, patients may also notice:

• Rapid heart rate
• Sudden pallor or shortness of breath
• Splenomegaly (enlarged spleen)

When to See a Doctor

Yellowing of the eyes should not be ignored, especially if it appears suddenly or is accompanied by any of the following:

• Fever > 38 °C (100.4 °F) or chills.
• Severe abdominal pain, especially with guarding or rebound tenderness.
• Persistent vomiting or inability to keep food/liquids down.
• Confusion, drowsiness, or difficulty concentrating.
• Dark urine or clay‑colored stools that last more than 24 hours.
• Rapid weight loss, swelling of the abdomen, or unexplained bruising.
• History of liver disease, heavy alcohol use, recent medication changes, or known gallstones.

Even if symptoms are mild, schedule an appointment promptly; early evaluation prevents complications and can identify life‑threatening conditions.

Diagnosis

Evaluating icterus involves a combination of history, physical examination, laboratory testing, and imaging.

1. Medical History & Physical Exam

• Onset, duration, and progression of yellowing.
• Alcohol consumption, medication/supplement use, travel, sexual history, and family history of liver disease.
• Physical findings: degree of scleral yellowing, skin jaundice, liver size, tenderness, ascites, and signs of chronic liver disease (spider angiomas, palmar erythema).

2. Laboratory Tests

• Serum bilirubin – total and direct (conjugated) levels help differentiate hemolytic vs. obstructive causes.
• Liver enzymes (ALT, AST, ALP, GGT) – patterns suggest hepatitis, cholestasis, or infiltrative disease.
• Complete blood count (CBC) – anemia or leukocytosis may point to hemolysis or infection.
• Prothrombin time/INR – assesses synthetic liver function.
• Viral hepatitis serologies, autoimmune markers (ANA, ASMA), iron studies, and ceruloplasmin when indicated.

3. Imaging Studies

• Abdominal ultrasound – first‑line to evaluate gallstones, biliary duct dilation, liver texture, and masses.
• CT or MRI – detailed view of pancreas, liver, and biliary tree if ultrasound is inconclusive.
• MRCP (magnetic resonance cholangiopancreatography) – non‑invasive visualization of the bile ducts.

4. Specialized Procedures

• Endoscopic retrograde cholangiopancreatography (ERCP) – diagnostic and therapeutic for biliary obstruction.
• Liver biopsy – reserved for unclear cases or suspected autoimmune, infiltrative, or metabolic liver disease.

Treatment Options

Treatment targets the underlying cause; the yellowing itself generally resolves once bilirubin levels fall.

1. Hepatic (Liver‑related) Causes

• Viral hepatitis – Antiviral regimens (e.g., tenofovir or entecavir for HBV; direct‑acting antivirals for HCV) as per CDC guidelines.
• Alcoholic liver disease – Complete abstinence, nutritional support, and corticosteroids for severe alcoholic hepatitis.
• Non‑alcoholic fatty liver disease – Weight loss (7‑10 % of body weight), exercise, and management of diabetes/hyperlipidemia.
• Cirrhosis complications – Diuretics for ascites, beta‑blockers for variceal bleed prophylaxis, and liver transplantation evaluation when decompensated.

2. Biliary Obstruction

• Gallstones – Endoscopic sphincterotomy with stone extraction (ERCP) or laparoscopic cholecystectomy.
• Pancreatic cancer or strictures – Surgical resection when feasible, stent placement via ERCP, and chemotherapy/radiation as per oncologic protocols.
• Primary sclerosing cholangitis / primary biliary cholangitis – Ursodeoxycholic acid for PBC; immunosuppression and bile‑duct drainage for PSC.

3. Hemolytic Disorders

• Address the trigger (e.g., stop offending drug, treat infection).
• Transfusions for severe anemia.
• Specific therapies: steroids for autoimmune hemolysis, hydroxyurea for sickle cell disease, or splenectomy in selected cases.

4. Symptomatic & Supportive Care

• Stay hydrated – helps kidneys clear excess bilirubin.
• Avoid alcohol and hepatotoxic substances.
• Phototherapy for severe neonatal jaundice (standard of care per WHO).
• Pruritus relief – cholestyramine, antihistamines, or rifampin for cholestatic itch.

5. Home Remedies (Adjunctive)

• Balanced diet rich in fruits, vegetables, lean protein, and whole grains.
• Milk thistle (silymarin) – limited evidence; discuss with a provider before use.
• Regular moderate exercise (150 min/week) to support liver health.

Prevention Tips

While not all cases are preventable, many risk factors are modifiable:

• Vaccinate against hepatitis A and B.
• Limit alcohol intake – no more than 1 drink/day for women, 2 for men.
• Maintain a healthy weight (BMI < 25) to reduce NAFLD risk.
• Practice safe sex and avoid sharing needles to prevent viral hepatitis.
• Use medications as prescribed; discuss herbal supplements with your doctor.
• Adopt a diet low in saturated fats and high in fiber.
• Stay up‑to‑date on routine health screenings (liver function tests if you have risk factors).
• Promptly treat infections, especially cholangitis or gallbladder disease.

Emergency Warning Signs

Key Take‑aways

Yellowing of the eyes is a visual cue that something is disrupting bilirubin metabolism. While some causes are fleeting (e.g., newborn physiologic jaundice), many are serious liver, biliary, or blood‑cell disorders that require prompt evaluation. Recognizing associated symptoms, understanding when to seek care, and adhering to preventive measures can dramatically influence outcomes.

References

• Mayo Clinic. “Jaundice.” https://www.mayoclinic.org
• CDC. “Hepatitis A Questions and Answers.” https://www.cdc.gov
• NIH National Institute of Diabetes and Digestive and Kidney Diseases. “Liver Disease.” https://www.niddk.nih.gov
• World Health Organization. “Management of Neonatal Jaundice.” https://www.who.int
• Cleveland Clinic. “Biliary Obstruction.” https://my.clevelandclinic.org
• American Association for the Study of Liver Diseases. “Guidelines for the Diagnosis and Management of Hepatitis C.” 2023.

```